Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardea Biosciences IncfiledCriticalArdea Biosciences Inc
Publication of HN2010002097ApublicationCriticalpatent/HN2010002097A/en
ESTA INVENCION SE REFIERE A COMPOSICIONES, METODOS PARA PREPARAR LAS COMPOSICIONES Y METODOS PARA TRATAR O PREVENIR ENFERMEDADES, QUE COMPRENDEN LA ADMINISTRACION DE LAS COMPOSICIONESTHIS INVENTION REFERS TO COMPOSITIONS, METHODS TO PREPARE COMPOSITIONS AND METHODS TO TREAT OR PREVENT DISEASES, UNDERSTANDING THE ADMINISTRATION OF COMPOSITIONS
HN2010002097A2008-03-122010-10-14
COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
HN2010002097A
(en)
NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.
ASSISTANT FORMULATIONS UNDERSTANDING COMBINATIONS OF TRITERPENOIDS, STEROLS, IMMUNOMODULATORS, POLYMERS AND STIMULATORS OF TH2, PREPARATION PROCEDURES, COMPOSITIONS AND APPLICATIONS.
Compounds derived from prostaglandin e2 inhibitor 2-arylamino-benzimidazoles (mpges-1); pharmaceutical composition that includes them; intermediary compounds; use in the treatment of inflammatory diseases and / or associated conditions, in particular pain.